Origin BioMed raises $3.8M for natural health products
Origin BioMed, a maker of natural-product skin creams and oils based in Halifax, Nova Scotia, raised $3.8 million in a first funding round. Avrio Ventures Limited Partnership led the round, joined by NSBI Venture Capital and several private individuals.
Origin plans to use the funds to drive its expansion into the U.S. market. Its leading product is Neuragen, a topical preparation for diabetic foot pain, whose active ingredients are purified versions of several “essential oils,” apparently including geranium oil.
Next Story: Lipomics raises $2.8M for metabolic diagnostics
Previous Story: FotoFlexer — a photo-editor that lets you transform yourself
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
